Hi-Tech Pharmaceuticals Fastin Fat Burner Pills
Hi-Tech Pharmaceuticals Fastin 60 Tabs
This is the NEW Formula of Fastin with DMHA!
With so many weight loss and diet aids saturating the market, it’s difficult to know which ones work and more importantly, which is the right one for you. Hi-Tech Pharmaceuticals’ Fastin is a premium fat burner that will provide you with clean energy, boost your mood, and suppress your appetite – without any of the crashing or jitters. Fans of Hi-Tech’s original Fastin formula will see the same mind-blowing results even though this version does not contain DMAA. This Fastin contains DMHA and boosts twice the caffeine content of the original (200mg) and uses a powerful blend of herbal stimulant compounds, chiefly being Phenylethylamine HCL, a popular stimulant most commonly referred to as PEA. Fastin works quickly to boost your energy levels and eliminate fatigue, alongside powerful appetite suppressants so you can fight against even the toughest cravings when your defenses are down. Fastin also supports a heightened sense of well-being and improved mood, so you can stay positive and motivated throughout your weight loss journey. Order your bottle of Fastin today and watch the fat melt away!
Hi-Tech Fastin Fat Burner Highlights
- Helps Support Your Weight Loss Journey
- Increased Energy & Endurance to Train Harder
- Helps Reduce Cravings, Sweet Tooths, and Suppresses Appetite
- Supports a Positive Mood & Mindset
- Provides Increased Focus & Mental Alertness
- Improves Endurance and Reduces Fatigue
Fastin Directions and Dosage
Hi Tech Pharmaceuticals recommends that you take 1-2 tablets in the morning on an empty stomach and then an additional tablet in the afternoon on an empty stomach. Do not exceed 4 tablets in one day. Due to the extreme potency, start within only 1 tablet in the morning and 1 tablet in the afternoon.
Hi-Tech Pharmaceuticals Fastin 60 Tablets Supplement Facts
Serving Size: 1 Tablet
Servings per Container: 60
Amount per serving % Daily Value
Proprietary Blend with Thermo-Rx: Phenylethylamine HCl, Methylsynephrine HCl, Theobromine Anhydrous, 2-Aminoisoheptane HCl, Synephrine HCl, N-Methyl-B-Phenylethylamine HCl, Yohimbine HCl 245mg *
Caffeine (anhydrous) 200mg *
*Daily Value not Established
Other ingredients: Dextrose, Microcrystalline Cellulose, Hydroxypropyl Methylcellulose, Stearic Acid, Magnesium Stearate, Sodium Starch Glycolate, Starch, Silica.
Warnings and Side Effects
Not for use by individuals under the age of 18 years. Do not use if you are pregnant or nursing. Individuals who consume caffeine with this product may experience serious adverse health effects. Individuals who are sensitive to the effects of caffeine should consult a licensed health care professional before consuming this product. In case of accidental overdose, seek professional assistance or contact a poison control center immediately. Avoid alcohol while taking this product. Do not exceed recommended serving. Exceeding recommended serving may cause serious adverse health effects, including heart attack and stroke. Discontinue use and call a physician or licensed qualified health care professional immediately if you experience rapid heart beat, dizziness, severe headache, shortness of breath, or other similar symptoms, improper use of this product may be hazardous to a person's health. Exceeding recommended serving will not improve results.
References
Icken D, Feller S, Engeli S, Mayr A, Müller A, Hilbert A, de Zwaan M. Caffeine intake is related to successful weight loss maintenance. Eur J Clin Nutr. 2016 Apr;70(4):532-4. doi: 10.1038/ejcn.2015.183. Epub 2015 Nov 11. PMID: 26554757.
https://pubmed.ncbi.nlm.nih.gov/26554757/
Martínez-Pinilla E, Oñatibia-Astibia A, Franco R. The relevance of theobromine for the beneficial effects of cocoa consumption. Front Pharmacol. 2015 Feb 20;6:30. doi: 10.3389/fphar.2015.00030. PMID: 25750625; PMCID: PMC4335269.
https://pubmed.ncbi.nlm.nih.gov/25750625/
Catalani V, Prilutskaya M, Al-Imam A, et al. Octodrine: New Questions and Challenges in Sport Supplements. Brain Sci. 2018;8(2):34. Published 2018 Feb 20. doi:10.3390/brainsci8020034